Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL – Get Free Report)’s stock price gapped down prior to trading on Monday . The stock had previously closed at $13.70, but opened at $13.12. Adlai Nortye shares last traded at $13.57, with a volume of 4,027 shares.
Analyst Upgrades and Downgrades
ANL has been the subject of several research analyst reports. HC Wainwright increased their price objective on Adlai Nortye from $16.00 to $20.00 and gave the stock a “buy” rating in a research report on Monday, April 20th. Leerink Partners initiated coverage on Adlai Nortye in a research report on Friday, March 20th. They issued an “outperform” rating and a $23.00 price objective for the company. Wall Street Zen upgraded Adlai Nortye to a “hold” rating in a research report on Saturday, March 7th. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of Adlai Nortye in a research report on Wednesday, January 21st. Two investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. According to data from MarketBeat, Adlai Nortye currently has a consensus rating of “Hold” and an average target price of $21.50.
Adlai Nortye Price Performance
Hedge Funds Weigh In On Adlai Nortye
A hedge fund recently raised its stake in Adlai Nortye stock. SmartHarvest Portfolios LLC raised its position in shares of Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL – Free Report) by 8.5% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 16,367 shares of the company’s stock after acquiring an additional 1,279 shares during the period. SmartHarvest Portfolios LLC’s holdings in Adlai Nortye were worth $113,000 at the end of the most recent reporting period. Institutional investors own 35.21% of the company’s stock.
About Adlai Nortye
Adlai Nortye Inc (NASDAQ: ANL) is a specialty chemical manufacturer headquartered in China’s Jiangsu Province. The company focuses on the research, development, production and sale of fine chemicals, with a primary emphasis on amino acids and their derivatives.
Adlai Nortye’s product portfolio includes betaine compounds, a range of high-purity L-amino acids such as L-methionine, L-threonine and glycine, as well as various chemical intermediates. These offerings serve multiple end markets, including animal feed and nutrition, personal care and cosmetic formulations, pharmaceutical ingredients and industrial chemical processes.
The company operates multiple production facilities alongside an in-house research and development center dedicated to process innovation and quality control.
Featured Stories
- Five stocks we like better than Adlai Nortye
- Before the Moon Base Gets Built, These 4 Companies Win
- Industrial Buybacks: Top Homebuilding Supplier Leads Buyback Increases
- 3 Stocks That Win If Inflation Surprises to the Downside
- MercadoLibre Boldly Invests in Growth: Discount Deepens
Receive News & Ratings for Adlai Nortye Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adlai Nortye and related companies with MarketBeat.com's FREE daily email newsletter.
-etf-logo-1200x675.png){kind=logo}
-etf-logo-1200x675.png){kind=logo}
